|
Human Immunodeficiency Virus-1
Associated Nephropathy (HIVAN):
Epidemiology, Pathogenesis, Histology,
Diagnosis, and Medical Management
(Vol
33/No. 3. On-line test expires: 06/30/2008)
|
To
receive continuing education credit, you must read the
information in this article and take an on-line post
test and fill out an on-line program evaluation form.
The certificate will then be generated for you as a
.pdf file which you can print out locally on your computer.
CE Certification by ANNA requires a handling charge
that must be paid by credit card. Pricing information
is available by clicking on the "Post-Test Evaluation"
link below.
|
|
|
|
Please
download and print the PDF file below:
|
|
|
|
Michelle L. Lochner, MSN, RN, FNP, CNN,
|
Michelle L. Lochner, MSN, RN, FNP, CNN, is
Staff Nurse, Inpatient Dialysis Unit/Division of
Nephrology and Hypertension, Mayo Clinic/Mayo
Medical Center, Rochester, MN. She is also a
Family Nurse Practitioner Intern at the Grand
Meadow Family Practice Clinic at the Mayo Health
System. She is a member of the Southeast Minnesota
Chapter of ANNA.
|
|
Andrea Wolf, BSN, RN,
|
Andrea Wolf, BSN, RN, is Staff Nurse,
Medical/Surgical/Transplant Intensive Care Unit,
Rochester Methodist Hospital at the Mayo Medical
Center, Rochester, MN.
|
Human immunodeficiency virus-associated nephropathy (HIVAN) is a very distinct, unique,
clinico-pathological syndrome, and a structural type of renal failure that is the most common
cause of chronic renal failure in patients who are HIV-seropositive. Early referral and a
long-term, primary care approach can improve patient outcomes. Careful adjustments of prescription
doses with regularly scheduled, and at times frequent, laboratory testing will yield
optimal health, improve the quality of life, and most importantly, will decrease the incidence
of morbidity and mortality in those individuals afflicted with both HIV and HIVAN.
|
|
CE
RELATED INFORMATION |
|
This
offering for 2.3 contact
hours is being provided by
the
American
Nephrology Nurses Association
(ANNA), which
is accredited as a provider
and approver of continuing
education in nursing by
the American Nurses
Credentialing Center-Commission
on Accreditation (ANCCCOA).
This educational activity
is approved by most states
and specialty organizations
that recognize the ANCC-COA
accreditation process. ANNA
is an approved provider of
continuing education in nursing
by the California Board of
Registered Nursing, BRN Provider
No. 00910; and the Kansas
State Board of Nursing, Provider
No. LT0148-0738. This offering
is accepted for RN and LPN
relicensure in Kansas
|
|
Goal:
Recognize human immunodeficiency virus-1 associated nephropathy (HIVAN)
as the most common cause of chronic kidney disease in patients who are HIVseropositive.
Objectives:
1.Discuss epidemiology and incidence of human immunodeficiency
virus-1(HIV-1) and HIVAN.
2.Describe the clinical presentation of HIVAN.
3. List the important components of diagnosis and treatment of HIVAN.
|
AUTHOR DISCLOSURE
STATEMENT |
Michelle L. Lochner has
no conflicts of interest to disclose.
Andrea Wolf has
no conflicts of interest to disclose.
|
ANNA and HDCN CE POLICY STATEMENTS |
The CE policy and disclosure statements of the American Nephrology
Nurses' Association are given in detail on the Symposium
Home Page. The CE policy statements of HDCN are listed on
this page. |